Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68081707%3A_____%2F17%3A00486058" target="_blank" >RIV/68081707:_____/17:00486058 - isvavai.cz</a>
Alternative codes found
RIV/61989592:15310/17:73583752
Result on the web
<a href="http://dx.doi.org/10.1039/c7dt02633a" target="_blank" >http://dx.doi.org/10.1039/c7dt02633a</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1039/c7dt02633a" target="_blank" >10.1039/c7dt02633a</a>
Alternative languages
Result language
angličtina
Original language name
Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA
Original language description
One of the promising new antitumor platinum complexes is a large-ring chelate complex [PtCl2(cis-1,4-DACH)] (DACH = diaminocyclohexane) (kiteplatin). Recently, new platinum(II) derivatives of kiteplatin with pyrophosphate as a carrier ligand have been synthesized and tested on a panel of human cancer cell lines. These derivatives of kiteplatin were found to be more effective than clinically used anticancer platinum drugs. The design of kiteplatin pyrophosphate derivatives was based on the concept of pyrophosphate coordinated platinum complexes, phosphaplatins. Phosphaplatins have been shown to function without binding to DNA and hence DNA has been excluded as the target of phosphaplatins in contrast to conventional antitumor platinum drugs. Cytotoxicity, major cellular targets and DNA interactions of the new anticancer platinum drug were characterized by standard biochemical methods and methods of molecular and cellular biology. We demonstrate that, in contrast to what has been reported on closely related phosphaplatins, the derivatives of kiteplatin with the pyrophosphate carrier ligand are activated in the cellular environment. This activation, which yields species capable of platination of DNA, very likely comprises the hydrolytic release of the pyrophosphate ligand that could be enzymatically catalyzed. Collectively, these data provide convincing evidence that unexpectedly DNA is an important target for the biological activity of the kiteplatin pyrophosphate derivatives, although the overall mechanism of action might be different from those of conventional platinum drugs.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Dalton Transactions
ISSN
1477-9226
e-ISSN
—
Volume of the periodical
46
Issue of the periodical within the volume
41
Country of publishing house
GB - UNITED KINGDOM
Number of pages
10
Pages from-to
14139-14148
UT code for WoS article
000413638400011
EID of the result in the Scopus database
—